Skip to content
★ Sign in to follow
JW

Jack W. Singer

Executive
CTI Biopharma Corp
Total declarations
158
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (128 ops.)
€818k

Latest filing published 23 Mar 2016 for CTI Biopharma CORP, €22k.

Insider track record

Disclosed buys
0
Disclosed sells
128
Signal history

Jack W. Singer: trading record in brief

Jack W. Singer appears in our data through filings on CTI Biopharma Corp shares, published by SEC (Form 4). The record holds 158 filings, for trades running from 11 December 2006 to 21 March 2016.

On the market, this insider has only sold: 128 sales, €818k in total. Outside the open market, there are 24 share grants. 2016 to date brings no purchases and 25 sales.

The record was last updated on 23 March 2016 with a share grant (€22k) in CTI Biopharma Corp. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Jack W. Singer

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations154 total
  • ◆
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    25,182 USD16SEC
    45,935 shares@ US$0.548247.3% of flowCommon StockSEC:0000891293-16-000133:0
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    62 USD26SEC
    100 shares@ US$0.6150.1% of flowCommon StockSEC:0000891293-16-000109:0
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    185 USD26SEC
    300 shares@ US$0.6180.4% of flowCommon StockSEC:0000891293-16-000109:1
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    124 USD26SEC
    200 shares@ US$0.620.2% of flowCommon StockSEC:0000891293-16-000109:2
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    317 USD26SEC
    510 shares@ US$0.6220.6% of flowCommon StockSEC:0000891293-16-000109:3
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    62 USD26SEC
    100 shares@ US$0.6230.1% of flowCommon StockSEC:0000891293-16-000109:4
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    125 USD26SEC
    200 shares@ US$0.6240.2% of flowCommon StockSEC:0000891293-16-000109:5
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    125 USD26SEC
    200 shares@ US$0.6250.2% of flowCommon StockSEC:0000891293-16-000109:6
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    189 USD26SEC
    300 shares@ US$0.630.4% of flowCommon StockSEC:0000891293-16-000109:7
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    63 USD26SEC
    100 shares@ US$0.6310.1% of flowCommon StockSEC:0000891293-16-000109:8
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    380 USD26SEC
    600 shares@ US$0.6330.7% of flowCommon StockSEC:0000891293-16-000109:9
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    2,530 USD26SEC
    3,990 shares@ US$0.6344.9% of flowCommon StockSEC:0000891293-16-000109:10
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    381 USD26SEC
    600 shares@ US$0.6350.7% of flowCommon StockSEC:0000891293-16-000109:11
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    719 USD26SEC
    1,130 shares@ US$0.6361.4% of flowCommon StockSEC:0000891293-16-000109:12
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    1,656 USD26SEC
    2,600 shares@ US$0.6373.2% of flowCommon StockSEC:0000891293-16-000109:13
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    2,086 USD26SEC
    3,270 shares@ US$0.6384.0% of flowCommon StockSEC:0000891293-16-000109:14
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    128 USD26SEC
    200 shares@ US$0.6390.2% of flowCommon StockSEC:0000891293-16-000109:15
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    64 USD26SEC
    100 shares@ US$0.6420.1% of flowCommon StockSEC:0000891293-16-000109:16
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    322 USD26SEC
    500 shares@ US$0.6430.6% of flowCommon StockSEC:0000891293-16-000109:17
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    2,370 USD27SEC
    2,000 shares@ US$1.18513.4% of flowCommon StockSEC:0000891293-16-000092:3
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    823 USD26SEC
    700 shares@ US$1.1754.6% of flowCommon StockSEC:0000891293-16-000092:1
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    359 USD26SEC
    300 shares@ US$1.1952.0% of flowCommon StockSEC:0000891293-16-000092:5
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    3,120 USD28SEC
    2,600 shares@ US$1.2017.6% of flowCommon StockSEC:0000891293-16-000092:6
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    2,142 USD27SEC
    1,800 shares@ US$1.1912.1% of flowCommon StockSEC:0000891293-16-000092:4
  • ▼
    EVP, Chief Scientific OfficerExecutivesCTI Biopharma Corp
    2,950 USD28SEC
    2,500 shares@ US$1.1816.6% of flowCommon StockSEC:0000891293-16-000092:2

25 of 154 declarations